Xlife Sciences AG (XSWX:XLS) FCF Margin % : 454.84% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Xlife Sciences AG FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Xlife Sciences AG's Free Cash Flow for the six months ended in Dec. 2023 was CHF2.91 Mil. Xlife Sciences AG's Revenue for the six months ended in Dec. 2023 was CHF0.64 Mil. Therefore, Xlife Sciences AG's FCF Margin % for the quarter that ended in Dec. 2023 was 454.84%.

As of today, Xlife Sciences AG's current FCF Yield % is 0.08%.

The historical rank and industry rank for Xlife Sciences AG's FCF Margin % or its related term are showing as below:

XSWX:XLS' s FCF Margin % Range Over the Past 10 Years
Min: -686.85 Med: -157.18 Max: 17.31
Current: 17.31

During the past 6 years, the highest FCF Margin % of Xlife Sciences AG was 17.31%. The lowest was -686.85%. And the median was -157.18%.

XSWX:XLS's FCF Margin % is ranked better than
90.49% of 1041 companies
in the Biotechnology industry
Industry Median: -141.21 vs XSWX:XLS: 17.31

Xlife Sciences AG FCF Margin % Historical Data

The historical data trend for Xlife Sciences AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG FCF Margin % Chart

Xlife Sciences AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-82.14

-157.18

-686.85

-455.93

13.26

Xlife Sciences AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial					-645.62	-936.02	-183.84	-787.36	454.84

Competitive Comparison of Xlife Sciences AG's FCF Margin %

For the Biotechnology subindustry, Xlife Sciences AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xlife Sciences AG's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xlife Sciences AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Xlife Sciences AG's FCF Margin % falls into.

Xlife Sciences AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Xlife Sciences AG's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	0.131	/	0.988
	=	13.26 %

Xlife Sciences AG's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	2.911	/	0.64
	=	454.84 %

Xlife Sciences AG FCF Margin % Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Xlife Sciences AG (XSWX:XLS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (XSWX:XLS) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

XLSz:UK

Address

Talacker 35, Zürich, CHE, 8001

Website

https://www.xlifesciences.ch

Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.

Xlife Sciences AG (XSWX:XLS) Headlines

No Headlines